Dr. Shankman will serve as a co-investigator on Dr. MacNamara’s R01 entitled “HARM-A: A neurobiological predictor of comorbidity and stress reactivity in anxiety disorders,” a project investigating neural indicators of negative valence constructs and comorbidity among internalizing disorders. Dr. Shankman will provide assistance in the analysis and write-up of the EEG and measures of negative valence constructs – central measures of the project (and designs/methods that he has a great deal of experience with). Dr. Shankman will also help the investigative team in the use and interpretation of the continuous version of the SCID diagnostic interview – a validated diagnostic interview in which skip-outs are minimized and yields dimensional assessments of psychopathology. Lastly, co-I Shankman will work with the investigative team regarding the EMA methods, as he is PI on two ongoing NIMH-funded R01s and a recently completed NIMH-funded R21 that each use EMA to study internalizing psychopathologies. Dr. Shankman has a track-record of working with the PI (he was a co-mentor on Dr. MacNamara’s K-award) and his work and expertise is complimentary but synergistic with the rest of the investigative team. None of the proposed work overlaps with any of Dr. Shankman’s other projects.
|Effective start/end date||5/15/21 → 3/31/26|
- Texas A&M University (M2102399//5R01MH125083-02)
- National Institute of Mental Health (M2102399//5R01MH125083-02)